Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury

Experimental and Molecular Pathology

Volumn 94, Issue 1, 2013, Pages 10-16

  Dorn, Christoph ^a   Massinger, Sabine ^b   Wuzik, Andreas ^b   Heilmann, Jörg ^c   Hellerbrand, Claus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b University of Regensburg ^*

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Inflammation; Liver; NF B; ROS; Warm ischemia reperfusion injury; Xanthohumol

Indexed keywords

AMINOTRANSFERASE; GLUTATHIONE; HEME OXYGENASE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; XANTHOHUMOL;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BAX GENE; BCL XL GENE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER INJURY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REOXYGENATION; REPERFUSION INJURY; TREATMENT RESPONSE; UPREGULATION;

ALANINE TRANSAMINASE; ANIMALS; CHEMOKINE CCL2; FLAVONOIDS; GLUTATHIONE; HEME OXYGENASE-1; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NF-KAPPA B; OXIDATIVE STRESS; PROPIOPHENONES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; WARM ISCHEMIA;

HUMULUS; MUS;

EID: 84870877147     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.05.003     Document Type: Article

References (54)

1. Abe Y., Hines I.N., Zibari G., Pavlick K., Gray L., Kitagawa Y., Grisham M.B. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radical Biology & Medicine 2009, 46:1-7.
2. Abu-Amara M., Yang S.Y., Tapuria N., Fuller B., Davidson B., Seifalian A. Liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transplantation 2010, 16:1016-1032.
3. Albini A., Dell'Eva R., Vene R., Ferrari N., Buhler D.R., Noonan D.M., Fassina G. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. The FASEB Journal 2006, 20:527-529.
4. Amann T., Bataille F., Spruss T., Dettmer K., Wild P., Liedtke C., Muhlbauer M., Kiefer P., Oefner P.J., Trautwein C., Bosserhoff A.K., Hellerbrand C. Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. American Journal of Pathology 2010, 176:1433-1442.
5. Bahde R., Spiegel H.U. Hepatic ischaemia-reperfusion injury from bench to bedside. British Journal of Surgery 2010, 97:1461-1475.
6. Beraza N., Ludde T., Assmus U., Roskams T., Vander B.S., Trautwein C. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. Gastroenterology 2007, 132:2504-2517.
7. Chen T., Zamora R., Zuckerbraun B., Billiar T.R. Role of nitric oxide in liver injury. Current Molecular Medicine 2003, 3:519-526.
8. Colgate E.C., Miranda C.L., Stevens J.F., Bray T.M., Ho E. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Letters 2007, 246:201-209.
9. de G.H., Rauen U. Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplantation Proceedings 2007, 39:481-484.
10. Dorn C., Bataille F., Gaebele E., Heilmann J., Hellerbrand C. Xanthohumol feeding does not impair organ function and homoeostasis in mice. Food and Chemical Toxicology 2010, 48:1890-1897.
11. Dorn C., Kraus B., Motyl M., Weiss T.S., Gehrig M., Scholmerich J., Heilmann J., Hellerbrand C. Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Molecular Nutrition & Food Research 2010, 54(Suppl. 2):S205-S213.
12. Dorn C., Weiss T.S., Heilmann J., Hellerbrand C. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells. International Journal of Oncology 2010, 36:435-441.
13. Ezaki T., Seo Y., Tomoda H., Furusawa M., Kanematsu T., Sugimachi K. Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease. British Journal of Surgery 1992, 79:224-226.
14. Fan C., Zwacka R.M., Engelhardt J.F. Therapeutic approaches for ischemia/reperfusion injury in the liver. Journal of Molecular Medicine (Berlin, Germany) 1999, 77:577-592.
15. Fukai M., Hayashi T., Yokota R., Shimamura T., Suzuki T., Taniguchi M., Matsushita M., Furukawa H., Todo S. Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radical Biology & Medicine 2005, 38:1372-1381.
16. Gabele E., Muhlbauer M., Dorn C., Weiss T.S., Froh M., Schnabl B., Wiest R., Scholmerich J., Obermeier F., Hellerbrand C. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochemical and Biophysical Research Communications 2008, 376:271-276.
17. Gabele E., Dostert K., Dorn C., Patsenker E., Stickel F., Hellerbrand C. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcoholism, Clinical and Experimental Research 2011, 35(7):1361-1367.
18. Galaris D., Barbouti A., Korantzopoulos P. Oxidative stress in hepatic ischemia-reperfusion injury: the role of antioxidants and iron chelating compounds. Current Pharmaceutical Design 2006, 12:2875-2890.
19. Gerhauser C., Alt A., Heiss E., Gamal-Eldeen A., Klimo K., Knauft J., Neumann I., Scherf H.R., Frank N., Bartsch H., Becker H. Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Molecular Cancer Therapeutics 2002, 1:959-969.
20. Glantzounis G.K., Salacinski H.J., Yang W., Davidson B.R., Seifalian A.M. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transplantation 2005, 11:1031-1047.
21. Gujral J.S., Bucci T.J., Farhood A., Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?. Hepatology 2001, 33:397-405.
22. Hartkorn A., Hoffmann F., Ajamieh H., Vogel S., Heilmann J., Gerbes A.L., Vollmar A.M., Zahler S. Antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury. Journal of Natural Products 2009, 72:1741-1747.
23. Hellerbrand C., Muhlbauer M., Wallner S., Schuierer M., Behrmann I., Bataille F., Weiss T., Scholmerich J., Bosserhoff A.K. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis 2006, 27:64-72.
24. Hussong R., Frank N., Knauft J., Ittrich C., Owen R., Becker H., Gerhauser C. A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats. Molecular Nutrition & Food Research 2005, 49:861-867.
25. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Proceedings of the Society for Experimental Biology and Medicine 1995, 209:104-111.
26. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006, 290:G1083-G1088.
27. Jaeschke H., Bautista A.P., Spolarics Z., Spitzer J.J. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. Journal of Leukocyte Biology 1992, 52:377-382.
28. Jaeschke H., Smith C.W., Clemens M.G., Ganey P.E., Roth R.A. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicology and Applied Pharmacology 1996, 139:213-226.
29. Klune J.R., Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. The Surgical Clinics of North America 2010, 90:665-677.
30. Li J.D., Peng Y., Peng X.Y., Li Q.L., Li Q. Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion injury. Transplantation Proceedings 2010, 42:1582-1586.
31. Liu P.T., Ioannides C., Symons A.M., Parke D.V. Role of tissue glutathione in prevention of surgical trauma. Xenobiotica 1993, 23:899-911.
32. Luedde T., Assmus U., Wustefeld T., Meyer zu Vilsendorf A., Roskams T., Schmidt-Supprian M., Rajewsky K., Brenner D.A., Manns M.P., Pasparakis M., Trautwein C. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. The Journal of Clinical Investigation 2005, 115:849-859.
33. Lupinacci E., Meijerink J., Vincken J.P., Gabriele B., Gruppen H., Witkamp R.F. Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha release in LPS-stimulated RAW 264.7 mouse macrophages and U937 human monocytes. Journal of Agricultural and Food Chemistry 2009, 57:7274-7281.
34. McCormack L., Dutkowski P., El-Badry A.M., Clavien P.A. Liver transplantation using fatty livers: always feasible?. Journal of Hepatology 2011, 54:1055-1062.
35. Miranda C.L., Stevens J.F., Ivanov V., McCall M., Frei B., Deinzer M.L., Buhler D.R. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. Journal of Agricultural and Food Chemistry 2000, 48:3876-3884.
36. Muhlbauer M., Bosserhoff A.K., Hartmann A., Thasler W.E., Weiss T.S., Herfarth H., Lock G., Scholmerich J., Hellerbrand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003, 125:1085-1093.
37. Nakajima H., Mizuta N., Fujiwara I., Sakaguchi K., Ogata H., Magae J., Yagita H., Koji T. Blockade of the Fas/Fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 2008, 13:1013-1021.
38. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
39. Parks D.A., Granger D.N. Ischemia-reperfusion injury: a radical view. Hepatology 1988, 8:680-682.
40. Rauen U., Viebahn R., Lauchart W., de G.H. The potential role of reactive oxygen species in liver ischemia/reperfusion injury following liver surgery. Hepato-Gastroenterology 1994, 41:333-336.
41. Schauer R.J., Gerbes A.L., Vonier D., Meissner H., Michl P., Leiderer R., Schildberg F.W., Messmer K., Bilzer M. Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia. Annals of Surgery 2004, 239:220-231.
42. Shin T., Kuboki S., Lentsch A.B. Roles of nuclear factor-kappaB in postischemic liver. Hepatology Research 2008, 38:429-440.
43. Stein H.J., Oosthuizen M.M., Hinder R.A., Lamprechts H. Oxygen free radicals and glutathione in hepatic ischemia/reperfusion injury. Journal of Surgical Research 1991, 50:398-402.
44. Stevens J.F., Page J.E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!. Phytochemistry 2004, 65:1317-1330.
45. Suetsugu H., Iimuro Y., Uehara T., Nishio T., Harada N., Yoshida M., Hatano E., Son G., Fujimoto J., Yamaoka Y. Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury. Gut 2005, 54:835-842.
46. Tacke F., Luedde T., Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clinical Reviews in Allergy & Immunology 2009, 36:4-12.
47. Teoh N.C. Hepatic ischemia reperfusion injury: contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly. Journal of Gastroenterology and Hepatology 2011, 26(Suppl. 1):180-187. 10.1111/j.1440-1746.2010.06584.x.
48. Tsuchihashi S., Fondevila C., Kupiec-Weglinski J.W. Heme oxygenase system in ischemia and reperfusion injury. Annals of Transplantation 2004, 9:84-87.
49. Vanhoecke B.W., Delporte F., Van B.E., Heyerick A., Depypere H.T., Nuytinck M., De K.D., Bracke M.E. A safety study of oral tangeretin and xanthohumol administration to laboratory mice. In Vivo 2005, 19:103-107.
50. Walsh K.B., Toledo A.H., Rivera-Chavez F.A., Lopez-Neblina F., Toledo-Pereyra L.H. Inflammatory mediators of liver ischemia-reperfusion injury. Experimental and Clinical Transplantation 2009, 7:78-93.
51. Yamaguchi N., Satoh-Yamaguchi K., Ono M. In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris. Phytomedicine 2009, 16:369-376.
52. Yen T.L., Hsu C.K., Lu W.J., Hsieh C.Y., Hsiao G., Chou D.S., Wu G.J., Sheu J.R. Neuroprotective effects of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus), in ischemic stroke of rats. Journal of Agricultural and Food Chemistry 2012, 60:1937-1944.
53. Zwacka R.M., Zhang Y., Zhou W., Halldorson J., Engelhardt J.F. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 1998, 28:1022-1030.
54. Zwacka R.M., Zhou W., Zhang Y., Darby C.J., Dudus L., Halldorson J., Oberley L., Engelhardt J.F. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nature Medicine 1998, 4:698-704.